Repeat Rituximab Courses Sustain Clinical Efficacy in Patients with RA Monthly Prescribing Reference SAN DIEGO, CA—A sustained improvement of clinical response was seen after each retreatment course with rituximab in patients with rheumatoid arthritis (RA), with respect to Treat to Target principles and EULAR/ACR recommendations, presented Catalin ... |
